Skip to main content

Akero Therapeutics, Inc. (NASDAQ: AKRO) Investor Securities Class Action Lawsuit 04/26/2024

  • If you purchased a significant amount of shares of Akero Therapeutics, Inc. (NASDAQ: AKRO) between September 13, 2022 and October 9, 2023, and / or if you purchased any NASDAQ: AKRO shares prior to September 2022 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: June 25, 2024. NASDAQ: AKRO investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

August 18, 2025 - The judge dismissed the case. May 26, 2025 - A second amended complaint was filed. May 5, 2025 - The court issued an order granting motion to dismiss. Leave was given to amend the complaint. November 18, 2024 - A motion was filed to dismiss the amended complaint. September 24, 2024 - An amended complaint was filed. April 26, 2024 - An investor in shares of Akero Ther...



You must register (for free) or login to view the entire case.